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Abstract: Precision nutrition aims to make dietary recommendations of a more personalized nature
possible, to optimize the prevention or delay of a disease and to improve health. Therefore,
the characteristics (including sex) of an individual have to be taken into account as well as a series
of omics markers. The results of nutritional genomics studies are crucial to generate the evidence
needed so that precision nutrition can be applied. Although sex is one of the fundamental variables
for making recommendations, at present, the nutritional genomics studies undertaken have not
analyzed, systematically and with a gender perspective, the heterogeneity/homogeneity in gene-diet
interactions on the different phenotypes studied, thus there is little information available on this
issue and needs to be improved. Here we argue for the need to incorporate the gender perspective
in nutritional genomics studies, present the general context, analyze the differences between sex
and gender, as well as the limitations to measuring them and to detecting specific sex-gene or
sex-phenotype associations, both at the specific gene level or in genome-wide-association studies.
We analyzed the main sex-specific gene-diet interactions published to date and their main limitations
and present guidelines with recommendations to be followed when undertaking new nutritional
genomics studies incorporating the gender perspective.
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1. Importance of Sex/Gender Differences in Precision Medicine and Precision Nutrition
In recent years, the concept of precision medicine or what is also called personalized medicine [1]
has become increasingly important. With the publication by Francis Collins [2], director of the
United States National Institutes of Health (NIH), announcing the new era of Precision Medicine and
the setting up of a nationwide cohort aimed at recruiting and undertaking follow-up on a million
individuals in order to generate omic and other types of data for precision medicine, research with this
precision perspective has intensified in all disciplines internationally. The field of nutrition has also felt
the general influence of the aims of precision medicine and, in recent years, has strongly developed
the concept of precision nutrition or personalized nutrition.
1.1. Precision Nutrition and Sex/Gender Differences
Currently, there is no single definition of precision nutrition, and although in most cases
precision nutrition is used as a synonym for personalized nutrition, several authors claim that
there may be a number of differences in the sense that precision nutrition could go further afield
than personalized nutrition [3]. In general, we can define precision nutrition as that which uses
information on the characteristics of an individual, including omic markers, to make more personalized
recommendations that could contribute to preventing or treating a disease in the best way possible [3–5].
Therefore, sex/gender, in addition to the other markers, is one of the most relevant variables for
precision nutrition.
For precision nutrition, it is essential to have omic markers available and not only genomic ones,
but increasingly epigenomic, metabolomics, transcriptomic and metagenomic ones, among others [5].
Furthermore, precision nutrition needs to have prior evidence gathered by nutrigenetic and
nutrigenomic studies available in order to make specific recommendations (Figure 1).
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1.2. Nutritional Genomics and Sex/Gender Differences
Precision nutrition cannot be undertaken without having prior findings available from
nutrigenetic and nutrigenomic research. Both disciplines form part of nutritional genomics and
are often used synonymously, but a difference can be established between them. Whereas nutrigenetics
studies the different response to diet depending on the genotype of the individual, nutrigenomics
studies the mechanisms through which different responses to diet, depending on genotype take place,
integrating various omics [6]. Despite the hundreds of studies published on nutritional genomics [7] in
recent years, much more research is required to attain a sufficient level of evidence for the knowledge
required to allow its practical application to precision nutrition. In general, the studies conducted
so far have presented low-level consistency when analyzing similar gene-diet interactions. Various
factors may have contributed to that, among them, and quite apart from problems related to study
design, are those associated with the characteristics of the population. Even though nutrition genomics
seeks to generate more specific results to make more personalized nutritional recommendations, these
studies have focused on genotype and other omic markers and have not paid sufficient attention
to other critical factors for personalizing diets such as age and sex/gender, among others. Having
not paid attention to the sex/gender variable of the participants may have contributed to different
studies analyzing the same gene-diet interactions and producing discordant results, especially if each
of those studies had included a different percentage of men and women and there had been a certain
heterogeneity per sex. Hence, the need to know the characteristics of the individuals better in with
precision nutrition, it is essential to conduct new nutritional genomic studies that take into account the
sex/gender of the participants. Thus, in this guide, we will present the current situation analysis from
the gender perspective in nutritional genomic studies, primarily in nutrigenetics, but also mentioning
several nutrigenomic aspects, focusing on the different intermediate and final phenotypes of the
leading chronic diseases related to nutrition. To do so, we will define the sex/gender perspective
and its specific application to nutritional genomic studies and present examples of studies that
have tackled the sex/gender perspective with greater or lesser complexity, as well as examples of
gene-sex-diet interactions and review their advantages and limitations. We will also analyze the
advances made in identifying biological sex, discuss the difficulty of genomic studies that analyze
genes in the sexual chromosomes by presenting several examples. Finally, we will make a series
of specific recommendations to be taken into account in the form of a guide to analyze data from
previously undertaken nutritional genomic studies and fundamentally for designing and conducting
new nutritional genomic studies with a sex/gender perspective.
2. General Context of Differences Per Sex and Gender Perspective in Biomedical Research and
Nutritional Genomics
Historically, women have had fewer opportunities in society than men [8]. The scientific field has
not been exempt from that, not only because most researchers and leaders have been men, but also
because, when it comes to biomedical research in humans, mainly through clinical trials, fewer women
have been analyzed than men. This means that many conclusions of biomedical studies have been
fundamentally obtained using results of what happens in men, and the results have been generalized
to directly include women without specifically analyzing them and without knowing whether their
response is different from men or not [9]. Thus, it has only been in recent decades, faced with the
claim that important differences may exist in risk factors, symptomology, treatment and prognosis of
various diseases between men and women, that both sexes have been studied in greater detail [10–15].
As important differences in various factors related to health and disease between men and women
are increasingly noted, specialist researchers and health planners are insisting on the increasing
need to carry out studies that include and compare men and women in order to better understand
similarities and differences and to be able to apply that knowledge effectively to disease prevention
and treatment [16]. It is becoming increasingly evident that ignoring the influence of sex in research
compromises the validity and generalizability of the findings and contributes to bringing about a
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stagnation or even regression instead of making progress on the level of evidence and scientific
knowledge. Hence, in recent years there has been an attempt to promote epidemiological studies that
adopt the sex/gender perspective, analyzing at least differences between men and women separately
when the study includes both [17,18].
Presenting results stratified by men and women allows us to have information available for
conducting meta-analyses and showing, with a higher level of evidence, whether or not differences
in the factor and/or disease studied exist between men and women. Nevertheless, few studies
exist that have presented results stratified by sex and, therefore, it is still complicated to conduct
meta-analyses of the studies published to obtain conclusions on this issue. As an example of this
situation, the conclusions arrived at in a meta-analysis carried out a few years ago by Doull et al. [19]
to examine the use of sex/gender analyses in systematic reviews of cardiovascular health. They chose
a random sample of 38 Cochrane systematic reviews addressing interventions for cardiovascular
diseases from 2001 to 2007. The general conclusion was that a sex/gender analysis was not considered
in the reviews examined and only 2 of 38 reviews reported any sex/gender research gaps. Moreover,
where sex or gender was mentioned, the terms were used interchangeably. The authors, therefore,
insisted on the need to promote the undertaking of original studies of men and women in order
to make data available at this level and, in parallel, to also promote the undertaking of systematic
reviews and meta-analyses using the sex/gender perspective. Without this information, it would not
be possible to build a robust evidence base for future analysis of evidence for decision-making.
One way of encouraging studies to be undertaken on men and women (or males and females in
studies on animals or cells) and to present separate data is for study-funding agencies to prioritize that
undertaking. In this context, The National Institutes of Health (NIH) Office of Research in Women’s
Health in the United States, under the efforts of Janine Clayton has issued a mandate to close the
knowledge gap on women’s health and sex/gender research in epidemiological studies in humans
as well as in the basic research arena [20,21]. These efforts, begun in 2014 and 2015, are having a
substantial impact on all related fields, from establishing guidelines on conducting and evaluating
studies [22–24]. In these recommendations, particular emphasis has been placed on basic research
studies and animal models, given that traditionally these studies have not reported on the sex of
animals, cells, or tissues used, so contributing to the ambiguity of knowledge that now exists on the
influence of sex in these studies. The announcement of the NIH in May 2014 insisted that studies
not only had to differentiate per sex, but to go further and specifically ensure that the investigators
account for sex as a basic biological variable (SABV) in NIH-funded preclinical research [23]. In Europe,
concern about the inclusion of a gender perspective in financed research began somewhat earlier. Quite
apart from the pioneering initiatives in several countries, such as Sweden and Switzerland, we should
also point out that the gender perspective has been a major initiative of the European Union gender
equality policy for research.
Gender perspective has many definitions, among which we should mention that made by the
Swiss Center of Expertise in Human Rights in 1997 and that has been taken up by the European Institute
of Gender Equality (EIGE) that defines it as a “Perspective taking into account gender-based differences
when looking at any social phenomenon, policy or process”. This perspective was applied to research
for the first time under Framework Program 5 (FP5). In 2000–2001, the European Commission (EC)
commissioned a series of Gender Impact Assessment (GIA) studies on FP5 to assess, among other
aspects, whether the lines of research prioritized in FP5 affected men and women differently [25].
This action aimed to obtain conclusions to be included in a gender perspective for the following
program (FP6). One of these GIA studies focused on the “Quality of Life and Management of
Living Resources” and had a subsequently wide impact given that its recommendations on the
importance of gender in research were later introduced for FP6 applicants [25]. Within this program,
the so-called GenderBasic Project (2005–2008) was conducted, whose main aim was to provide scientists
involved in health related research (including both basic and clinical research) funded by the EU,
with practical tools and best practices regarding sex/gender analysis in those projects. The outcome of
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this project was the publication of 10 reviews in the journal Gender Medicine entitled “Bringing Gender
Expertise to Biomedical and Health-Related Research” [26], as well as making recommendations on
promoting the gender perspective in the following PF7 [25]. One of the reviews published in the Gender
Medicine special was conducted by Prof. José Ordovás, and focused on the influence of gender in
gene-environment interactions [27]. It was later, in 2013, when the analysis of sex/gender variables in
the research projects of the EU [28] was prioritized still further. Among the more pioneering countries
in encouraging sex/gender analyses in research projects in Canada, which in 2010, had already
established several formal recommendations for research projects [29]. In parallel, different public and
private bodies in various countries have been incorporating the gender perspective into their calls
for projects by positively evaluating this approach in their criteria, both in basic and clinical research.
All these initiatives directly related to introducing the gender perspective into biomedical research
would not have been possible without the immense prior work of pioneering individuals, institutions
and bodies on the gender perspective in society as a whole, and are too numerous to mention here
in greater detail. On the international level we can mention the policy on gender perspective of the
World Health Organization (WHO), as in the document “Integrating gender perspectives in the work
of WHO: WHO gender policy”, published in the year 2002 [30]. Table 1 provides various Web links
containing information related to gender perspective in the most important institutions and bodies of
the same.
Table 1. Web links containing information related to gender perspective.
Webpage URL
Gendered innovations: http://ec.europa.eu/research/swafs/gendered-innova-tions/index_en.cfm
Gender innovations Stanford University https://genderedinnovations.stanford.edu
eGender platform (Germany): http://egender.charite.de
http://www.euro.who.int/en/health-topics/health-determinants/gender/gender-definitions
The Sex and Gender Medical Education Summit (USA): http://www.sgbmedu-cationsummit.org
The Sex and Gender Women’s Health Collaborative (USA): www.sgwhc.org “Every cell has a sex, and all
bodies are influenced by gender”.
The Gender Awakening Tool (Canada): http://www.cwhn.ca/en/node/43342—Sex and Gender in Systematic
Reviews: Planning Tool (USA): http://methods.cochrane.org/equity/sex-and-gender-analysis
Toolkit Gender in EU Funded Research (EU): https:
//publications.europa.eu/es/publication-detail/-/publication/c17a4eba-49ab-40f1-bb7b-bb-6faaf8dec8
The Center for Gender Medicine (CfGM) in the Karolinska Institutet (Sweden):
http://ki.se/en/research/centre-for-gender-medicine
Institute of Gender and Health (IGH) of Canadian Institutes of Health Research (Canada):
http://www.cihr-irsc.gc.ca/e/48641.html
https://www.who.int/gender-equity-rights/understanding/gender-definition/en/
http://www.gendermedicine.org/index.php?q=node/375 European Society of Gender Health Medicine
http://www.whrn.ca/better-science. Primer published by the Women’s Health Research Network (WHRN),
Canada promoting sex and gender-based analyses in health research.
https://www.ag.gov.au/Publications/Documents/
AustralianGovernmentGuidelinesontheRecognitionofSexandGender/
AustralianGovernmentGuidelinesontheRecognitionofSexandGender.pd
In addition to these considerations, another aspect to be taken into account is that in clinical
trials people decide on whether or not they want to participate in these studies. In an ideal world,
it would be great to have a mix of men and women. However, if the research focuses on breast
cancer, for example, which affects many more women than men, it would be practically impossible to
achieve a similar number of both men and women participants. Nonetheless, despite these limitations,
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and apart from when health problems mostly affect only one of the sexes, efforts have to be made to
optimize the representation of men and women in studies.
Currently the concept of Gender Mainstreaming is being implemented as an international strategy
to ensure gender equality [31]. According to EIGE, Gender Mainstreaming:
“involves the integration of a gender perspective into the preparation, design, implementation,
monitoring and evaluation of policies, regulatory measures and spending programs, intending to
promoting equality between women and men, and combating discrimination” [31].
3. Difference Between Sex and Gender
So far in this work, we have used the words sex and gender without pointing out the difference,
but we are now going to make the distinction. Among the less expert research into gender perspective,
there is confusion in the meanings of both words. Most scientific works have used sex and gender as
synonyms which has added to the confusion. Although there is no total agreement between different
authors, there is more of an agreement on the definition of sex than on gender. Table 2 shows various
definitions of sex and gender with their respective references [32–36]. In general, sex is defined as a
biological construct based on two different chromosomal configurations (XX as opposed to XY) and on a
set of biological processes related to sexual beings. In analyses designed to study differences per sex, this is
treated as a dichotomous variable. However, gender is a much more complicated variable and is defined
as a socio-cultural and political construction that determines the relationship between people, granting
benefits and access to resources to those that find themselves in higher positions in a gender hierarchy.
Thus, gender would not be a dichotomous variable but a continuous variable because it defines
psychological, behavioral, cultural and political characteristics that are expressed in a wide range of
situations, which, moreover, can be dynamic. Both men and women can present a range of different
gender points and can even be overlapping. According to these gender definitions, a person’s sex and
gender may not necessarily be the same. Some people can identify themselves as being of a different
gender to the sex they were born with. There can even be people who, during one stage of their lives
identified themselves more with the masculine gender and in another with the feminine gender [36].
Thus, given these definitions, it is not correct to use sex and gender as synonyms in health research.
Various guides have been published aimed at directing researchers, editors and the reviewers of
different journals on how to analyze data, present results and make conclusions to prepare articles
for publications in journals. Among these are the SAGER (Sex and Gender Equity in Research)
Guidelines [37] that contain very detailed information on the different aspects to integrate sex and
gender assessment into manuscripts.
3.1. Sex and Gender Identification in Studies on Nutritional Genomics
To apply the gender perspective to nutritional genomics studies we need to obtain information on
the sex and gender variables. A priori, sex has a clearer definition and is easier to measure. However,
gender has a more complicated definition, and we cannot always measure it well in nutritional
genomics studies due to the lack of information on the other variables required for its definition.
Table 2. Sex and gender definitions.
Sex Definition Gender Definition Reference
The different biological and physiological
characteristics of males and females, such as
reproductive organs, chromosomes,
hormones, etc.
Refers to the socially constructed characteristics of
women and men–such as norms, roles and
relationships of and between groups of women and
men. It varies from society to society and can be
changed—including how they should interact with
others of the same or opposite sex within households,
communities and work places.
WHO [32]
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Table 2. Cont.
Sex Definition Gender Definition Reference
Refers to a set of biological attributes in
humans and animals. It is primarily
associated with physical and physiological
features including chromosomes, gene
expression, hormone levels and function,
and reproductive/sexual anatomy. Sex is
usually categorized as female or male but
there is variation in the biological attributes
that comprise sex and how those attributes
are expressed.
Refers to the socially constructed roles, behaviours,
expressions and identities of girls, women, boys, men,
and gender diverse people. It influences how people
perceive themselves and each other, how they act and
interact, and the distribution of power and resources in
society. Gender is usually conceptualized as a binary
(girl/woman and boy/man) yet there is considerable
diversity in how individuals and groups understand,
experience, and express it.
CIHR [33]
Refers to biological differences between
females and males, including chromosomes,
sex organs, and endogenous
hormonal profiles.
Refers to socially constructed and enacted roles and
behaviors which occur in a historical and cultural
context and vary across societies and over time.
All individuals act in many ways that fulfill the gender
expectations of their society. With continuous
interaction between sex and gender, health is
determined by both biology and the expression
of gender.
NIH [34]
Biological and physiological characteristics
that define humans as female or male.
Social attributes and opportunities associated with
being female and male and to the relationships
between women and men and girls and boys, as well
as to the relations between women and those
between men.
EIGE [35]
Refers to the chromosomal, gonadal and
anatomical characteristics associated with
biological sex.
It is a part of a person’s personal and social identity.
It refers to the way a person feels, presents and is
recognized within the community. A person’s gender
may be reflected in outward social markers, including
their name, outward appearance, mannerisms
and dress.
Australian
Government
[36]
WHO: World Health Organization; CIHR: Canadian Institutes of Health Research; NIH: National Institutes of
Health; EIGE: European Institute of Gender Equality.
3.1.1. Measuring Sex in Nutritional Genomics Studies
Generally speaking, in nutritional genomics studies, sex is a self-reported variable. Often the
man or woman question is included in the questionnaires and the individual identifies himself or
herself with one of the two categories. Sometimes it is the researcher who assigns the participant to
the male or female sex by their name, appearance, etc. Nevertheless, various definitions of sex such
as those presented in Table 2, indicate that sex “refers to biological differences between females and
males, including chromosomes, sex organs, and endogenous hormonal profiles” [34]. With regard
to differences in chromosomes, a recent work published in JAMA by Janine A Clayton and Cara
Tannembaum [38], from the Office of Research on Women’s Health of NIH, Bethesda, recommends that,
in an article, the “sex” variable of the participants be included in an initial table on the characteristics
of the sample studied, stating the number of male and female participants and using, for that purpose,
a genotyping technique on a blood sample of the participants. Although employing a genotyping
technique is a good approach to determining sex, and allows us to indirectly assess the karyotype
(46,XY (male) or 46,XX (female)), this is not feasible for all studies. Clayton and Tannembaum [38], after
recommending the presentation of the “sex” variable as males and females determined by genotyping
in the laboratory, also recommend presenting the “gender” variable in the first table, as the number
of men and women ascertained by self-report. This recommendation may confuse, as in the normal
situations of epidemiological and nutritional genomics studies, sex has been self-reported and not
determined genetically.
In terms of genetic sex, various genotyping techniques that determine the sex of an individual
from a blood sample have been validated. Initially the amelogenin test (frequently used in forensics)
was used, based on determining length polymorphisms in AMEL genes [39]. Our research group used
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this test to analyze the concordance between the sex determined by genotyping and self-reported
sex [39]. We genotyped 1,224 individuals participating in a biomedical study, and the overall
concordance rate was 99.84% (1222/1224). Two samples showed a female amelogenin test outcome,
being codified as males in the database, and we then identified them as coding errors or sample
handling mistakes [39]. Some years ago, without taking the gender perspective into account,
we concluded that the undertaking of sex determining analyses by genotyping could be very useful as
a means of quality control. However, there is also the possibility that several discrepancies, quite apart
from the errors of the amelogenin test itself, are due to individuals with a certain chromosomal sex
(for example: XY), reporting a different gender (woman, in this case), but this would not constitute an
error at the genotyping level (being a real difference between the biological sex and the reported gender).
There are now more advanced techniques for determining sex through next generation sequencing
(NGS) [40], or through panels of selected polymorphisms that could easily be used in nutritional
genomics studies that have genome-wide genotyping available for quantifying the discrepancies.
However, whilst this genotyping possibility is technically available, most studies into nutritional
genomics have determined sex through a self-reporting method, instead of by genotyping.
On the suggestion of classifying sex through genotyping techniques, other authors argue that we
have to consider whether “sex” should be restricted to reproductive differences between males and
females, or extended to include all biological differences between males and females [41,42]. Moreover,
researchers in a qualitative study [42] thought that the traditional definition of “sex” was not sufficient
for understanding the biological body, stressing “it was difficult to define where ‘sex’ and ‘gender’
started and ended as the concepts were seen as intertwined”.
Finally, with regard to biological sex being determined through different techniques in the
laboratory, we have to bear in mind that, although affecting a very small number of people, there are
other chromosomal alterations that give rise to more or less undetermined sexes, such as 45,X; 47,XXY;
45,X/46,XY, among others that have been widely discussed in a consensus review [43].
3.1.2. Gender Measurement in Nutritional Genomics Studies
Measuring gender is still more difficult than measuring sex in biomedical research studies
and nutritional genomics in particular [16,32–36,41,42,44]. Despite there being many definitions,
they generally agree on stating that gender “is a multidimensional social construct that is culturally
based and historically specific, and thus constantly changing” [44]. It, therefore, refers to the socially
prescribed and experienced dimensions of "femaleness" or "maleness" in a particular society, and is
manifested at many levels. Given the difficulty of definition, from a practical point of view it is
necessary to know which variables can provide the best information in order to classify individuals
into the different genders, either generally or specifically for each type of study. Although several
advances have been made [45,46], there is still little consensus on how to measure the factors that
determine gender and how many categories of gender can be validly analyzed and compared. As the
gender perspective is increasingly incorporated into nutrition genomics studies, better indicators and
metrics will be developed to measure the gender variable more accurately. One example of these
developments is the work of Pelletier et al. [47] who created a gender-score in order to measure the
gender variable in women and men participants in GENESIS-PRAXY (GENdEr and Sex determInantS
of cardiovascular disease: From bench to beyond-Premature Acute Coronary SYndrome). First,
they selected variables to form part of the scale and with them created a score from 0 to 10 points.
A higher score meant a more feminine gender. On using this variable, they observed that patients
with characteristics traditionally ascribed to women were more likely to experience a recurrent acute
coronary syndrome than patients with characteristics traditionally ascribed to men, independently of
biological sex [47]. Similar developments in the field of nutritional genomics are necessary to measure
gender better in each type of study.
Other approaches to measuring gender have been based on gender identity and sexual orientation.
Thus, a study undertaken on a large sample of college students [48] to discover the relationship between
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gender and eating-related pathology posed the gender question (female, male and transgender),
as well as sexual orientation (heterosexual, gay/lesbian, bisexual or unsure). Using these questions,
they created a variable with 7 levels (trans-gender, cis-gender sexual minority men, cis-gender
unsure men, cis-gender heterosexual men, cis-gender sexual minority women, cis-gender unsure
women, and cis-gender heterosexual women). They observed a higher association between the
trans-gender and cis-gender sexual minority and eating disorders.
4. Measuring the Difference in Outcomes Depending on Sex/Gender
Nutritional genomics studies the interaction between genes and diet determining the intermediate
or final phenotypes of disease. When it comes to designing a study of this type, it is critical to know a
priori whether differences exist between men and women in the phenotypes of disease to better direct
the genetic and environmental variables to be determined in the sample studied. Although some years
ago there was no stratified information on the outcomes, thanks to the influence of research into gender
perspective we now have more information revealing these differences. Among them the review of
Giovannella Baggio et al. [49] entitled “Gender Medicine: a task of the third millennium”, which
discusses the influence of sex/gender in five fields of medicine: Cardiovascular diseases, oncology, liver
diseases, osteoporosis and pharmacology. In parallel, other authors have also revealed the enormous
influence of gender in ophthalmology [50,51] and on different aspects of the metabolism [52], among
other disease phenotypes.
5. Gender Perspective in Genotype Analyses in Nutritional Genomics Studies
In nutritional genomics studies a key point is the selection of the genes and gene variants
to be included in the analysis. Initially, genes and gene variants, basically single nucleotide
polymorphisms (SNPs), were chosen based on candidate genes and a gene variant functionality
approach [7]. However, after undertaking genome-wide association studies (GWAS), most nutritional
genomics studies have focused on the main SNPs identified through GWAS, either in isolation or
jointly by calculating so-called genetic risk scores (GRS) [53]. Nevertheless, most of these GWAS have
not taken into account the gender perspective and few studies have undertaken an analysis stratified
by men and women. For this reason, we believe that there is still a lack of essential information on
the central genes and/or SNPs that specifically can have a differential function in men and women.
Having that information would allow us to design better studies on sex-specific gene-diet interactions
and to develop so-called sex-specific GRS instead of working with the less specific global GRS, as has
been done for other obesity-specific GRS [54].
Besides these considerations, one has to bear in mind when analyzing polymorphisms in the
sexual chromosomes that there are limitations in traditional statistical analyses, given that women have
two X chromosomes and no Y chromosome. Therefore, the statistical analysis for polymorphisms in
chromosomes X and Y are difficult and should be adapted, instead of excluded for the present GWAS.
More GWAS including X and Y chromosomes should be promised [55]. Moreover, several X
chromosomes in women may escape inactivation, so opening up a new field of research on the
epigenetic level [55–57]. We shall now move on to review the main findings in detecting SNPs
differentially associated with disease phenotypes in men and women, as well as their limitations.
Sex-specific SNPs Associated with Disease, Current State of the Genome-Wide Association Studies
It is well-known that there are metabolic reactions that are regulated differently in males
and females, and therefore, sexual dimorphism is apparent in many diseases such as obesity,
diabetes or cardiovascular diseases [58]. However, apart from differences in hormone effects,
the XX and XY chromosomes contribute to such variance. For example, using four core genotypes
mouse models, Chen et al. [59] found that the sex chromosomes, independently from gonadal sex,
play a role in adiposity (more subcutaneous fat deposit in females and visceral in males), feeding
behavior, fatty liver, and glucose homeostasis, with higher risk for XX chromosome complement than
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XY [60]. The contribution of the X chromosome to the haploid human genome is 5% with around
800 protein-encoding genes out of the total 20,000 genes [61]. It seems quite relevant to study then,
the influence of sex differences associated with disease. However, while during the genomic era an
increasing number of GWAS have tried to detect SNPs associated with diseases, only around 30 %
included the X chromosome in their analysis [62]. The challenges associated with the X-chromosome
(described in the next section), is probably the reason why few studies are analyzing the association
between SNPs in the X chromosome and different traits. In contrast, we found more studies applying
sex-stratified analysis in GWAS. Table 3 shows a summary of some markers associated with different
traits in chromosome X or markers identified in sex-stratified GWAS [63–78].
Tukiainen et al. [63] aimed to assess the contribution of 404,862 chromosome X SNPs to
cardiometabolic and anthropometric traits in Finnish and Swedish individuals. The authors found
that the rs182838724 near FGF16/ATRX/MAGT1 and the rs1751138 near ITM2A were associated with
height in females and the rs139163435 in Xq23 with fasting insulin in males. In addition, variants
near ITM2A showed escape from X chromosome inactivation highlighting the value of accounting
for potential sex heterogeneity when assessing chromosome X associations. Another study assessing
the male specific region of the human Y chromosome, which has been identified as a candidate for
gender-related differences in the development of cardiovascular diseases, found that the TBL1Y(A)
USP9Y(A) haplotype of the Y chromosome, present only in people of African origin, was associated
with better profiles of lipoprotein patterns [64].
Ohlsson et al. [65] found an SNP in the X chromosome associated with lower concentrations
of testosterone. Testosterone levels in males are important because lower concentrations have been
associated with cardiovascular mortality, osteoporosis, metabolic syndrome, and type 2 diabetes.
These polymorphisms may assist in the identification of males at risk of low serum testosterone,
with potential clinical use in future studies [65]. Other SNPs identified include the rs5934507 in the
locus Xp22.31 associated with bone metabolism or some X or Y- genes associated with psychiatric
disorders [79].
Studies assessing sex-stratified GWAS also provide useful information. Winkler et al. [67]
performed a meta-analysis with genome-wide chip and Metabochip from the Genetic Investigation of
Anthropometric Traits (GIANT) Consortium to look at sex-specific effects of gene variants on BMI or
waist to hip ratio. They found 28 loci with larger effects in females than in males, five in males than in
females, and 11 showed opposite effects between sexes and waist to hip ratio [67]. Randall et al. [68]
identified three novel anthropometric trait loci (near MAP3K1, HSD17B4, PPARG), all of which had
genome-wide significance in females (p < 5 × 10(−8)), but not in males. Most of the SNPs identified in
GWAS with different effect in males than in females are located in genes that have relevant functions
to metabolism related to cardiovascular and associated diseases. For example, the PPARG gene plays a
role in diabetes genetics and therapy. Thus, the results from stratified analysis also provide important
evidence on the biology underlying sex differences in many important diseases. This is notable since
many diseases should be approached differently based on gender differences, and clinically can have
a meaningful impact on the treatment of diseases. Although the research is emerging, the sex-gene
specific associations are clearly understudied and, given the implications, there is an imperative need
to study and treat disease through sex/gender informed research.
Table 3. Examples of Sex-specific SNPs associated with different traits.
Author SNP/Loci/Gene Trait Sex-Specific Chromosome
Tukiainen et al.,
2014 [63]
ITM2A, FGF16
ATRX/MAGT1 (Xq23) (no
associated gene)
Height
Fasting insulin levels
Female (height)
Male (fasting
insulin)
X
Russo Paola et al.,
2008 [64] TBL1Y, USP9Y
Lower triglycerides (TG) and
higher HDL Male Y
Estrada et al.,
2012 [65]
Rs5934507 (Xp22.31, closest
gene FAM9B/KAL1 Bone metabolism Male X
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Table 3. Cont.
Author SNP/Loci/Gene Trait Sex-Specific Chromosome
Ohlsson et al.,
2011 [66]
rs5934505 in the X
Chromosome near FAM9B Lower testosterone levels Male X
Winkler et al.,
2015 [67] 44 loci
Changes in body mass index
(BMI), measures of body size,
or waist-to-hip ratio
Female (28) and
male (5) and 11
opposite effects
Autosome
chromosomes
Randall et al.,
2013 [68]
GRB14/COBLL1,
LYPLAL1/SLC30A10,
VEGFA, ADAMTS9,
MAP3K1, HSD17B4, PPARG
Anthropometrics (specifically
waist phenotypes) Female 2,1,6,3,5,5,3
Heid et al.,
2010 [69]
RSPO3, VEGFA, GRB14,
LYPLA1, ITPR2-SSPN,
ADAMTS9
Waist-to-hip ratio Female 6,6,2,1,12,3
Porcu et al.,
2013 [70]
PDE8B, PDE10A,
MAF/LOC440389,
LPCT2/CAPNS2,
NETO1/FBXO15
Affect thyroid stimulating
hormone (TSH) and Free
thyroxine (FT4) levels
Male (first 4) and
Female (last 1) 5,6,16,16,18
Kitamoto et al.,
2015 [71] ADIPOQ (2 SNPs out of 7)
Decrease serum adiponectin
levels which are correlated
with decreased homeostatic
model assessment-insulin
resistance (HOMA-IR)
Female 3
Mittelstrass et al.,
2011 [72] CSP1
Sex-specific association
with glycine Female and male 2
Teslovich et al.,
2010 [73] KLF14, ABCA8
Sex-specific association with
TG, LDL-C Female 7,17
Aung et al.,
2014 [74] ZNF259 Many lipid associations Male and Female 11
Lee, Kwon, &
Park, 2017 [75] CYP11β2
Salt sensitive gene leads to
obesity from salt-intake? Female 8
Nilsson et al.,
2011 [76] PRL Sex-specific obesity Male 6
Sun et al.,
2014 [77] GCKR, SLC2A9, SF1
Associated with serum uric
acid concentrations Male 2,4,9
Sung et al.,
2016 [78]
BBS9, ADCY8, KCNK9
MLLT10/DNAJC1/EBLN1
Visceral fat
Subcutaneous fat Women 10,8
Methodology/Limitations
Techniques to evaluate and identify SNPs have improved considerably over the last decade.
Nowadays, platforms such as Affymetrix Axiom Exome Genotyping Arrays, or the Illumina
HumanOmni5-Quad BeadChip include hundreds of thousands or millions of markers and from those,
some thousands or less (depending on the company) are specific to chromosome X. Many previous
GWAS studies have simply not included sex chromosomes in their analyses, despite being assayed
on all GWAS microarray platforms [62]. What was different in the past was that genotyping chips
contained very few X-chromosome markers. Still several reasons have been given for why variants in
the X chromosome are difficult to assess compared to autosomal chromosomes and why they have not
been included in GWAS analyses. These include lack of coverage on GWAS chips, differences in the
number of genes or variants on the X chromosome compared to the autosomes. Females have two
copies of X chromosome and males only one, thus males might cluster differently from females, and so
the statistical analysis and interpretation of the X chromosome can be a challenge. Differences in the
minor-allele frequency of variants on the X chromosome (the expected frequencies are sex dependent),
or the fact that current standard sequencing technologies cannot distinguish variants in the silenced
X chromosome provide other reasons (random X inactivation in women could neglect important
associations) [61,62]. Further limitations include the lack of powerful statistical tests and challenges
analyzing data due to previous complications. Chen and colleagues [80] proposed a new model of
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analysis, Xcat, that makes the assumption that the at-risk allele is the same for both males and females
if the SNP on the X chromosome is associated with the disease for both genders. However, there is no
consensus on how to handle X chromosome information and each study has used different methods.
For example, some studies have accounted for Hardy-Weinberg equilibrium, X-linked SNPs, and X
inactivation [81,82], but very few of the GWAS have used specific methods other than PLINK (that does
not take into account X inactivation) [83]. As previously discussed, those challenges have led to an
increased number of sex-stratified analyses in autosome chromosomes rather than X chromosomes.
To summarize, based on the evidence there are still very few studies assessing the variants in the
X chromosome. Neglecting the inclusion of variants in the sex-chromosomes can certainly increase
disparities and misinformation on how to better apply knowledge for personalized treatments and
counseling of a disease, given that sex and gender are critical determinants of health [14–16,84].
6. Specific Sex/Gender Gene-Diet Interactions
Most studies carried out on nutritional genomics have analyzed gene-diet interactions without
taking the gender perspective into account. Various factors have contributed to that, but fundamentally
we could point to the lack of awareness among researchers of the importance of study design and the
corresponding analyses, taking that perspective into account. Despite this, several published studies
have indeed analyzed gene-diet interactions in men and women separately and which have found
several specific interactions. Table 4 presents in greater detail some of the more relevant studies that
have found sex-specific associations in nutritional genomics [85–105]. In general, great heterogeneity
is detected when it comes to presenting results, as many studies do not undertake a formal statistical
analysis of the sex-gene-diet interaction term, limiting themselves to presenting the results of the
stratified analyses on men and women, without taking into account the statistical significance of the
interaction term indicating the statistical heterogeneity and justifying or not a stratified analysis. Often
the problem of not carrying out a formal analysis of the sex-gene-diet interaction term resides in the
sample size, given that it is necessary to analyze a large sample size in order to be able to detect an
interaction term as statistically significant on that level, and it is not always possible to achieve the
high number of participants required. On other occasions, it is simply that the authors did not think
about carrying out that calculation. Therefore, greater standardization is required on how to undertake
studies to increase the quality of the results obtained.
Out of the sex-specific associations presented in Table 4, it is difficult to know how many of
them are truly physiological differences depending on sex, or how many are simply the result of
statistical false positives (type I errors), as on undertaking the analyses of two groups, the probability
of finding a statistically significant association purely by chance is increased. This fact, as well
as the increased cost of studies by having to include a greater sample size of men and women to
achieve greater statistical power, has often been criticized for limiting the incorporation of the gender
perspective [25]. However, an improvement in study design and statistical analysis plan can minimize
those problems. Moreover, the possibility of introducing other complementary omics (epigenomics,
transcriptomics, metabolomics, etc.) and collaborations with other researchers to try to replicate the
results obtained will be crucial for validating sex-specific gene-diet interactions and distinguishing
them from false negatives in the analyses. Most of the studies presented in Table 4 focus on gene-diet
interactions by analyzing gene variants [85–100], as these are the type of studies that have mostly been
published to date. However, with the development of omics sex-specific gene-diet interactions at the
epigenomic level are now being analyzed, for example, those studies reporting on the methylation
level in Table 4 [101,102]. We have also included in Table 4 other studies that have found specific sex
differences in the changes that diet produces in the microbiome/metagenome [103,104]. All these
studies will increase in the coming years, and it is essential that they incorporate the gender perspective
given these initial differences.
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Table 4. Selected studies analyzing sex-specific gene-diet interactions in determining different phenotypes.
Author Study Characteristics and Aims Findings
Ordovas JM et al.,
2002 [85]
Examined whether dietary fat
modulates the association between the
APOA1 G-A polymorphism and
HDL-in men and women from the
Framingham Study.
We found a significant gene-diet interaction
associated with the APOA1 G-A polymorphism.
In women carriers of the A allele, higher
polyunsaturated fatty acid (PUFA) intakes were
associated with higher HDL-cholesterol
concentrations, whereas the opposite effect was
observed in G/G women.
Ribalta J et al.,
2005 [86]
Identification of gender-specific genetic
influences on fasting and postprandial
TG concentrations under typical living
conditions in healthy, lean,
normolipidemics.
An adverse combination of common alleles of the
FABP-2, APOE, and PPARgamma genes in women
increases their TGs to values comparable to those
seen in men. Although this influence is not
appreciable when studying fasting plasma TGs,
it becomes apparent with use of a more
sensitive index.
Méplan C et al.,
2007 [87]
Analysis of polymorphisms in the
selenoprotein P gene determine the
response of selenoprotein markers to
selenium (Se) supplementation in a
gender-specific manner
(the SELGEN study).
Two common functional SNPs within the human
SePP gene that may predict behavior of biomarkers
of Se status and response to supplementation and
thus susceptibility to disease. Both SNPs and gender
were associated with differences in scavenger
glutathione peroxidase 3 (GPx3) activity and
other markers.
Hu M et al.,
2012 [88]
Intervention with a high-carbohydrate
(high-CHO) diet for a short-term and
investigation of the interactions with the
hepatic lipase G-250A promoter
polymorphism to affect the ratios of
plasma lipids and apolipoproteins.
The high-CHO diet induced the positive effects on
the lipid ratios in general, only except the
TG/HDL-C ratio in females. Noticeably, the
decreased apoB100/apoAI ratio was associated with
the A allele of hepatic lipase G-250A polymorphism
only in males.
Shatwan IM et al.,
2016 [89]
Analysis of the influence of two
commonly studied LPL polymorphisms
(rs320, HindIII; rs328, S447X) on
postprandial lipaemia, in 261
participants using a standard sequential
meal challenge.
Novel finding on the effect of the LPL S447X
polymorphism on the postprandial glucose and
gender-specific impact of the polymorphism on
fasting and postprandial TAG concentrations in
response to sequential meal challenge in healthy
participants. The sex-specific results were only
detected in men.
Jacobo-Albavera L
et al., 2015 [90]
Analysis of whether gender,
menopausal status and macronutrient
proportions of diet modulate the effect
of the (ABCA1) R230C variant on
various metabolic parameters.
First study reporting a gender-specific interaction
between ABCA1/R230C variant and dietary
carbohydrate and fat percentages affecting Visceral
adipose tissue (VAT) / subcutaneous adipose tissue
(SAT) ratio, gamma-glutamyl transpeptidase (GGT),
alkaline phosphatase (ALP), adiponectin levels and
HOMA index. This study confirmed a previously
reported gender-specific ABCA1-diet interaction
affecting HDL-C levels.
Zhang Z et al.,
2011 [91]
Investigation of the association between
the sterol regulatory element-binding
protein-1c gene (SREBP-1c) rs2297508
and the changes in lipid profiles in a
high-carbohydrate and low-fat diet in a
Chinese population.
The C allele of the rs2297508 polymorphism was
associated with a retardation of the increases in
serum triacylglycerol, serum insulin, and HOMA-IR
in females and with the elevated serum HDL-C in
males after the high-carbohydrate/low fat
(high-CHO/LF) diet.
Barragán R et al.,
2018 [92]
Analyzed the age influence on the
intensity rating of the five basic tastes:
sweet, salty, bitter, sour and umami
(separately and jointly in a “total taste
score”) and their modulation by sex and
genetics in a relatively
healthy population.
Women perceived taste significantly more intense
than men (p = 1.4 × 10−8 for total taste score).
Significant associations were, found between a
higher perception of sour taste and a higher
preference for it in women. In contrast, the higher
perception of sweet was significantly associated with
a higher preference for bitter in both, men and
women. The TAS2R38-rs713598 SNP had a
significant interaction with sex.
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Table 4. Cont.
Author Study Characteristics and Aims Findings
Lauritzen L et al.,
2017 [93]
Mendelian randomization study to
explore whether SNPs in fatty acid
desaturase (FADS) and elongase
(ELOVL) genes were associated with
school performance in a
sex-specific manner.
Associations between rs1535 minor allele
homozygosity and rs174448 major allele carriage and
improved performance in boys but not in girls was
found, thereby counteracting existing sex differences.
Obregón AM et al.,
2017 [94]
Analysis of the association between the
DRD2 rs1800497 polymorphism and
eating behavior in Chilean children.
In the sex-specific analysis, the TaqI A1 allele was
associated with higher scores on Satiety
Responsiveness and Emotional Undereating
subscales in obese girls, and higher scores of
Enjoyment of Food subscale in boys.
Roumans NJ et al.,
2015 [95]
Investigation of whether genetic
variation in extracellular matrix (ECM)
-related genes is associated with weight
regain among participants of the
European DiOGenes study.
Variants of ECM genes were associated with weight
regain after weight loss in a sex-specific manner.
Ericson U et al.,
2013 [96]
Interaction analysis between IRS1
rs2943641 and macronutrient intakes on
incident T2D and percentage body fat in
the Malmö Diet and Cancer cohort.
The IRS1 rs2943641 interacted with carbohydrate and
fat intakes on incident T2D in a sex-specific manner.
A protective association between the rs2943641 T
allele and T2D was restricted to women with low
carbohydrate intake and to men with low fat intake.
Dedoussis GV et al.,
2011 [97]
Investigation of the age-related
association between the Pro12Ala
variant (rs1801282) and diet in
obesity-related traits in children.
Adiposity in children was influenced by the
Pro12Ala polymorphism in a sex-specific and
age-dependent manner.
Nettleton JA et al.,
2009 [98]
Analysis of whether dietary
macronutrient intake modified
associations between ANGPTL4[E40K]
variation and TG and HDL-C in White
men and women from the
Atherosclerosis Risk in
Communities study.
In men, but not women, the inverse association
between carbohydrate and HDL-C was stronger in A
allele carriers (beta+/-S.E. -1.80+/-0.54) than
non-carriers (beta+/-S.E. -0.54+/-0.11, p(interaction)
= 0.04 in men and 0.69 in women; p 3-way
interaction = 0.14).
Gastaldi M et al.,
2007 [99]
Analysis of the effect of fatty acid
binding protein 2 (FABP2) Ala54Thr
and microsomal triacylglycerol transfer
protein (MTTP) -493G/T variations on
plasma lipid markers, at baseline and on
the response to the 3-mo
Medi-RIVAGE study.
These 2 polymorphic loci are thus differently
associated with the baseline lipid markers as well as
with the response to nutritional recommendations,
but both presented a marked sex-specific profile,
with the response to diet being particularly efficient
in men homozygous for the MTTP -493T allele.
Alkhalaf A et al.,
2015 [100]
This study investigated whether 5L-5L
in the CNDP1 gene was associated with
mortality and progression of renal
function loss and to what extent this
effect was modified by sex.
The association between CNDP1 and cardiovascular
mortality was sex-specific, with a higher risk in
women with 5L-5L genotype. CNDP1 was not
associated with all-cause mortality or change in
epidermal growth factor receptor (EGFR).
van Dijk SJ et al.,
2016 [101]
A double-blind randomized
placebo-controlled trial in pregnant
women to test whether a defined
nutritional exposure in utero,
docosahexaenoic acid (DHA), could
alter the infant epigenome.
Maternal DHA supplementation during the second
half of pregnancy had small effects on DNA
methylation of infants. However, the number of
differential methylated loci (DMRs) at birth was
greater in males (127 DMRs) than in females
(72 DMRs) separately, indicating a
gender-specific effect.
Gonzalez-Nahm S
et al., 2017 [102]
Association between maternal
adherence to a Mediterranean diet
pattern during pregnancy and infant
DNA methylation at birth.
There was an association between overall diet
pattern and methylation at the 9 DMRs analyzed and
suggests that maternal diet can have a sex-specific
impact on infant DNA methylation at specific
imprinted DMRs.
Borgo F et al.,
2018 [103]
Comparison of the gut microbiota is in
at least two separate microbial
populations, the lumen-associated
(LAM) and the mucosa-associated
microbiota (MAM). Next generation
sequencing was used).
LAM and MAM communities seemed to be
influenced by different host factors, such as diet and
sex. Female MAM was enriched in Actinobacteria
(with an increased trend of the genus Bifidobacterium),
and a significant depletion in Veillonellaceae.
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Author Study Characteristics and Aims Findings
Bolnick DI et al.,
2014 [104]
Analysis of the factors related to the
composition of gut microbiota, mainly
the host genotyping.
The results indicated that microbiota composition
depends on interactions between host diet and sex
within populations of wild and laboratory fish,
laboratory mice and humans. The diet-microbiota
associations were sex dependent. Further
experimental work confirmed that microbiota was
different males versus females and suggested that
therapies to treat dysbiosis might have
sex-specific effects
Also in Table 4, we detected great heterogeneity in the use of the word sex and gender, which
were employed as synonyms. In none of these studies is an additional analysis undertaken to try
to define gender on any scale and to better analyze the gene-diet-gender interactions at this level.
This aspect will, therefore, have to be addressed in newly designed studies. Furthermore, one has
to bear in mind that sex and gender also interact. They do so specifically for each health problem
analyzed and for each exposure, so that one of the crucial points will be to improve information on the
exposure variables and their covariates in nutritional genomics.
7. Improvement in Diet Measurement and Other Related Variables Using Gender Perspective in
Nutritional Genomics
In nutritional genomics studies one of the major limitations is measuring diet, given that genetic
analyses are based on objective laboratory methods, whereas the diet (apart from in strictly controlled
intervention studies) is measured through food frequency questionnaires with a strong subjective
component that is also subject to recall bias, etc. [105]. Besides that, one has to take into account
that most questionnaires have been jointly designed and validated for men and women and are not
sex-specific, so that if we take into account that portion size can be different for men and women, as well
as other sex-related differences in food consumption [106], new studies would have to be conducted
in order to design and validate more sex-specific diet questionnaires as well as to incorporate new
technologies in order to improve diet measuring [107]. In parallel, we have stated earlier on that
sex and gender interact [108], so in new nutritional genomics studies we would have to pay more
attention to measuring variables more related to reproductive health in women, which have so far not
been incorporated in studies that do not specifically investigate it. These variables can be critical in
understanding the new environmental modulators in the sex-gender interrelationship. For example,
information would have to be available on menarche, menopause, full term pregnancy, age of
pregnancy, increase in body-weight, whether weight gain changed during pregnancy, undertaking
breastfeeding, maternal leave, and care of children, etc. [109–111]. There would also have to be more
detailed information available on other lifestyle dimensions in which gender differences are important.
All of that would provide us with greater knowledge to be incorporated into a better analysis of the
gene-diet interactions in nutritional genomics studies with a gender perspective.
8. Recommendations on the Design, Analysis, and Presentation of Results in Nutritional
Genomics Studies with a Gender Perspective
Following the above-detailed analysis assessing the present situation of studies published on
nutritional genomics, we will now make several recommendations, as guidelines, on improving the
design, analysis, and presentation of results in nutritional genomics:
a. Get to know the generalities of the gender perspective, the basic concepts and the importance
of generating knowledge that will allow us to understand better whether the risk factors of disease
(genetic and environmental), their evolution, prognosis and treatments are equal or differ depending
on sex/gender.
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b. Conduct a literature review of the topic of interest to be investigated including the gender
perspective in order to detect the main results as regards genetic and nutritional factors that have an
influence on the outcomes and identify the differences per sex/gender that there may be or the gaps
that have still not been investigated at this level.
c. Identify whether differences per sex/gender or intermediate phenotypes have been reported in
the outcomes and plan the analysis in men and women in accordance with the differences reported by
calculating the sample size of each of the groups.
d. Identify whether differences have previously been reported on the effect of the gene variants of
interest in the study depending on sex to be able to better design and set the aims of the study and
to establish the sample size following those differences. Focus on sex-specific GRS and mechanistic
gene-GRS diet interactions.
e. Identify whether differences in the effect of the diet variables of interest in the study per
sex/gender have previously been described in order to also take those differences into account in the
design of the study, sample size estimation, and statistical analyses.
f. To set the objectives of the study and chose the epidemiological design that will provide the
highest level of evidence for the specific characteristics of each investigation and the means available
for carrying it out. The study objectives have to consider, mainly as the primary aim, detecting
sex/gender differences in the topic that is being analyzed. Ensure adequate representation of males
and females and justify reasons for the exclusion of males or females. If it is only possible to include
one of the sexes due to the specificity of the health problem analyzed or for funding reasons, this point
should be indicated.
g. Choose the methodology for determining sex and gender. Given that nutritional genomics
studies often have genome-wide genotyping data available, this data can be used to analyze sex
genotypically and compare it with self-reported sex. Although determining gender is more complex,
nutritional genomic researchers should work on creating and validating new metrics for measuring
gender in these studies.
h. Improve the measuring of diet variables by using the gender perspective (improving
food frequency questionnaires specific to sex and introducing new technologies to capture food
consumption, etc.).
i. Improve the measuring of other variables related to lifestyle by incorporating the gender
perspective to analyze information that has so far not been fully analyzed (reproduction variables in
women, etc.)
j. Undertake an analysis plan specifying the statistical analyses to be carried out according to
a series of “a priori” and not “a posteriori” hypotheses, testing the gene-diet-sex interactions and
undertake and interpret the stratified analyses in accordance with them. The influence of sex/gender
should be assessed “a priori” on the basis of their hypothesized role in the gene-diet interactions,
causation or impact on the outcome of the health problem analyzed. Doing so minimizes false positives,
but one also has to be careful with the false negatives that will have to be interpreted correctly within
the statistical power framework of the study.
k. In addition, data should be reported disaggregated by sex/gender (as main or supplemental
material, depending on the study aims) regardless of the positive or negative results for future pooling
in the meta-analyses.
l. Try to have replication cohorts available in order to analyze the sex-specific results and
interactions found to increase the level of evidence if initial results are replicated in other cohorts.
m. Integrate the analyses of other omics to understand the mechanisms better and provide more
evidence on the differential effects per sex.
n. Present the results for publication following the guidelines for studies on sex, gender equity in
research, such as those of SAGER.
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9. Conclusions
The incorporation of the gender perspective into nutritional genomics studies will contribute to
improving the methodology of those studies as well as the validity of results, and will allow us to
obtain new knowledge on gene-diet interactions and other associations that may differ in men and
women, thus contributing to making more personalized prevention or treatment possible within the
new precision nutrition/precision medicine framework.
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